The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's
Clinical trial NCT03649724 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03649724
- Sponsor
- Weill Medical College of Cornell University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-27
- Primary completion
- 2026-07-25
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.